Table:
begin	end	state
1	32	signal peptide
33	274	non-cytoplasmic
275	299	transmembrane
300	307	cytoplasmic
308	324	transmembrane
325	329	non-cytoplasmic
330	350	transmembrane
351	361	cytoplasmic
362	380	transmembrane
381	410	non-cytoplasmic
411	430	transmembrane
431	457	cytoplasmic
458	480	transmembrane
481	495	non-cytoplasmic
496	520	transmembrane
521	527	cytoplasmic
528	548	transmembrane
549	563	non-cytoplasmic

Input:
>WP_015817423.1 NCBI__GCF_000023025.1:WP_015817423.1
MKYTKSTAILLLVSILVMATHSFAQAPVAEAQEESVTAEETVGSEATALQFETLVSQLTQ
RSFSKKAKVIEQLTQIKDPRILPTLKVMLDGDLYYQKADDQIVTVQNAADGVQPTSVITG
QLLALVGKRDVKKVTINNTLRRELRKAIAVLELSDVDSDVRRESARNLIKSPDADLRDTI
AQSAASETDNTVKHLLEVALALIDIDSADPSLRLGATRKLGGAVEPEAVAVLKRLAQRNE
QGQFVEPDNAVAKLAEERLKSVETKLSFFKFSENLLFGLSLGSVLLLAAIGLAITFGVMG
VINMAHGEMIMLGAYTTFAIQQLFPSLIDISLFLAIPAAFLVSGSAGVLIERLVIRHLYG
RPLDTLLATFGISLILQQAVRTYRANNVPVVTPDWMSGSWLINGAMSVTLNRVYILLFAL
FVLFMLALLLRKTLVGLQMRAVTQNRAMATSMGIRSNWVDALTFGLGSGIAGIAGVALSQ
ITNVGPNLGQSYIIDSFMVVVFGGVGNLLGTFVGAMSLGVVNKFLEPVTGAVIGKIIVLI
FIILFIQWRPRGLFALKGRFVED

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server